Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelics and health behaviour change
Pedro J. Teixeira, Matthew W. Johnson, Christopher Timmermann, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 1, pp. 12-19
Open Access | Times Cited: 59

Showing 1-25 of 59 citing articles:

Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical review
Michiel van Elk, David B. Yaden
Neuroscience & Biobehavioral Reviews (2022) Vol. 140, pp. 104793-104793
Open Access | Times Cited: 106
History repeating: guidelines to address common problems in psychedelic science
Michiel van Elk, Eiko I. Fried
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 51
Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
Marvin M. Urban, Moritz R. Stingl, Marcus W. Meinhardt
Frontiers in Neuroscience (2023) Vol. 17
Open Access | Times Cited: 40
Pattern breaking: a complex systems approach to psychedelic medicine
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 38
Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective
John R. Kelly, Claire M. Gillan, Jack Prenderville, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 50
Psychedelic perceptions: mental health service user attitudes to psilocybin therapy
Kate Corrigan, Maeve Haran, Conor McCandliss, et al.
Irish Journal of Medical Science (1971 -) (2021) Vol. 191, Iss. 3, pp. 1385-1397
Open Access | Times Cited: 45
Psychedelics and sexual functioning: a mixed-methods study
Tommaso Barba, Hannes Kettner, Caterina Radu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
What Predicts Beneficial Outcomes in Psychedelic Use? A Quantitative Content Analysis of Psychedelic Health Outcomes
Elias C. Acevedo, Scott Uhler, Kaitlyn P. White, et al.
Journal of Psychoactive Drugs (2024), pp. 1-10
Closed Access | Times Cited: 6
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
Drummond E-Wen McCulloch, Matthias E. Liechti, Kim P. C. Kuypers, et al.
Neuroscience Applied (2024) Vol. 3, pp. 103938-103938
Open Access | Times Cited: 5
Associations between lifetime classic psychedelic use and cardiometabolic diseases
Otto Simonsson, Walter Osika, Robin Carhart‐Harris, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 36
The economics of psychedelic-assisted therapies: A research agenda
Elliot Marseille, Stefano Bertozzi, James G. Kahn
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 25
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Tripping in the Happiest Country of the World – Use Values of Psychedelics According to Finnish Users
Mika Tsupari, Matilda Hellman, Tuukka Tammi
Contemporary Drug Problems (2025)
Closed Access
Psychedelic-assisted Therapy as a Promising Treatment for Irritable Bowel Syndrome
Erin E. Mauney, Franklin King, Helen Burton Murray, et al.
Journal of Clinical Gastroenterology (2025)
Closed Access
Exploring the Role of Psychedelic Experiences on Wellbeing and Symptoms of Disordered Eating
Nadine Loh, David Luke
Psychoactives (2025) Vol. 4, Iss. 1, pp. 7-7
Open Access
Exploring Serotonergic Psychedelics as a Treatment for Personality Disorders
Brennan M. Carrithers, Daniel E. Roberts, Brandon Weiss, et al.
Neuropharmacology (2025), pp. 110413-110413
Closed Access
Associations between psychedelic-related and meditation-related variables: a longitudinal study
Otto Simonsson, Sankalp Chaturvedi, Peter S. Hendricks, et al.
Journal of Psychiatric Research (2025)
Closed Access
Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research
Julia Bornemann, James B. Close, Meg J. Spriggs, et al.
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 29
Integration in Psychedelic-Assisted Treatments: Recurring Themes in Current Providers’ Definitions, Challenges, and Concerns
Mitch Earleywine, Fiona Low, Carmen Lau, et al.
Journal of Humanistic Psychology (2022)
Closed Access | Times Cited: 18
Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation
Matthew W. Johnson
Current topics in behavioral neurosciences (2022), pp. 213-227
Closed Access | Times Cited: 18
Classic psychedelics, health behavior, and physical health
Otto Simonsson, Peter S. Hendricks, Richard Chambers, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 17
Seeking the Psilocybiome: Psychedelics meet the microbiota-gut-brain axis
John R. Kelly, Gerard Clarke, Andrew Harkin, et al.
International Journal of Clinical and Health Psychology (2022) Vol. 23, Iss. 2, pp. 100349-100349
Open Access | Times Cited: 16
Transpersonal Ecodelia: Surveying Psychedelically Induced Biophilia
Alexander Irvine, David Luke, Freya Harrild, et al.
Psychoactives (2023) Vol. 2, Iss. 2, pp. 174-193
Open Access | Times Cited: 10
A role for the serotonin 2A receptor in the expansion and functioning of human transmodal cortex
Andrea I. Luppi, Manesh Girn, Fernando E. Rosas, et al.
Brain (2023) Vol. 147, Iss. 1, pp. 56-80
Open Access | Times Cited: 10
Psilocybin and Other Classic Psychedelics in Depression
David Nutt, Joseph Peill, Brandon Weiss, et al.
Current topics in behavioral neurosciences (2023), pp. 149-174
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top